UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000026948 |
|---|---|
| Receipt number | R000030908 |
| Scientific Title | Screening for adiponectin secretion using Adipose-derived stem cells in metabolic syndrome |
| Date of disclosure of the study information | 2017/04/11 |
| Last modified on | 2019/01/07 11:50:16 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Screening for adiponectin secretion using Adipose-derived stem cells in metabolic syndrome
Acronym
Screening for adiponectin secretion using Adipose-derived stem cells in metabolic syndrome
Scientific Title
Screening for adiponectin secretion using Adipose-derived stem cells in metabolic syndrome
Scientific Title:Acronym
Screening for adiponectin secretion using Adipose-derived stem cells in metabolic syndrome
Region
| Japan |
Condition
Condition
obesity
Classification by specialty
| Endocrinology and Metabolism | Gastrointestinal surgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Screening of adiponectin secretion-promoting drugs / foods with adipose derived stem cells (ADSC) that isolated from surgically collected adipose tissue of obese.
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Adiponectin level in adipocyte culture supernatant
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1. over BMI25kg/m2
2. Patient undergoing obesity surgery at Osaka University hospital
3. Patient who got written consent from himself / herself
Key exclusion criteria
1. <20 years old
2. Have severe infection
3. pregnant
4. The doctor in charge judges it as inappropriate as a subject.
Target sample size
60
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Toshinori ITO |
Organization
Osaka University Graduate School of Medicine
Division name
Department of Integrative Medicine
Zip code
Address
2-2, Yamadaoka, Suita, OSAKA
TEL
06-6879-3498
mikity@cam.med.osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Miki Sakaue |
Organization
Osaka University Graduate School of Medicine
Division name
Department of Integrative Medicine
Zip code
Address
2-2, Yamadaoka, Suita, OSAKA
TEL
06-6879-3498
Homepage URL
mikity@cam.med.osaka-u.ac.jp
Sponsor or person
Institute
Department of Integrative Medicine, Osaka University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Department of Integrative Medicine, Osaka University Graduate School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 04 | Month | 11 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 08 | Month | 12 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 08 | Month | 25 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study will search for secretagogues of adiponectin in vitro.
Management information
Registered date
| 2017 | Year | 04 | Month | 11 | Day |
Last modified on
| 2019 | Year | 01 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030908
